Here, we demonstrated that enoxacin treatment may slightly enhance ATF3 levels in ALS, suggesting that the general upregulation of miRNA levels can be beneficial by regulating key genes that modulate pathological phenotypes. Here, ATF3 is linked to amyotrophic lateral sclerosis.